• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Cleveland Clinic Taps Theranos for Innovative Lab Testing

by Fred Pennic 03/10/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Cleveland_Clinic_logo

Cleveland Clinic and Theranos Inc. have formed a long-term strategic alliance designed to improve patient care through innovation utilizing Theranos’ CLIA-certified laboratory services. Under the new alliance, Cleveland Clinic’s best-in-class pathology team in the Robert J. Tomsich Pathology and Laboratory Medicine Institute will collaborate with Theranos to provide advanced clinical diagnostic services and, over time, implement Theranos’ groundbreaking, CLIA-certified laboratory services within Cleveland Clinic’s patient populations.

“This alliance with a world-renowned health system like Cleveland Clinic furthers our mission, and is another step in our work to bring access to high-quality, affordable lab testing to everyone and help improve the quality and cost of care”

Theranos and Cleveland Clinic

Theranos offers a full spectrum of laboratory tests, from the most common panels to highly specialized tests, on blood samples as small as a few drops. This eliminates the need for larger needles and numerous vials of blood required for many diagnostic lab tests. Theranos’ minimally invasive sample collection will serve patients such as those receiving oncologic, pediatric and other inpatient treatment requiring frequent blood draws. Theranos tests are also priced at 50 percent of Medicare reimbursement rates or less to reduce the overall cost of care.

“Healthcare innovation is essential to making care more accessible, affordable and timely for patients. This relationship could open up new opportunities for both patients and physicians to be part of high-quality, low-cost healthcare,” said Toby Cosgrove, M.D., President and CEO of Cleveland Clinic. “We’re excited to begin exploring new initiatives that can offer improved care for our patient’s healthcare dollar.”

As part of the strategic alliance, Theranos and Cleveland Clinic will include opportunities to pursue research studies, clinical trials, the development of new tests, and the provision of reference laboratory services through Cleveland Clinic Laboratories. The collaboration may also extend to other Cleveland Clinic hospitals and family health centers.

Theranos currently provides its laboratory services through its network of Theranos Wellness Centers, located inside select Walgreens stores across Arizona and in Northern California.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |